Chloroquine (CQ) |
Acute confusional state,28 delirium,29 decreased deep tendon reflex, depression, extrapyramidal disorders,30 seizure31
|
Myopathy,32 neuromuscular disease, polyneuropathy |
Hydroxychloroquine (HCQ) |
Ataxia, vertigo, dizziness, sensorineural hearing loss, neurosis, psychosis, seizure |
Myopathy33
|
Umifenovir |
Dizziness, psychiatric symptoms (0.83%)34
|
|
Lopinavir/Ritonavir |
Fatigue, headache, anxiety (4%), insomnia |
Weakness, myalgia |
Interferon alpha |
Fatigue, headache, depression, drowsiness (1 to 33%), dizziness, vertigo, malaise, paresthesia, confusion (≤12), insomnia |
Myalgia, asthenia, musculoskeletal pain, arthralgia, back pain |
Favipiravir |
Psychiatric reactions (1.72%)34
|
|
Remdesivir |
Have not reported yet. |
Have not reported yet. |
Tocilizumab |
Headache, dizziness (rare) |
Chronic inflammatory demyelinating polyneuropathy (<1%) |
Corticosteroids |
Psychosis (14%),35,36 mania (28%), depression (41%), delirium,36 anxiety,36 insomnia,36 seizure, vertigo, paresthesia,37 pseudotumor cerebri38,39
|
Myopathy,40 neuropathy41,42
|